JP2002514634A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514634A5
JP2002514634A5 JP2000548320A JP2000548320A JP2002514634A5 JP 2002514634 A5 JP2002514634 A5 JP 2002514634A5 JP 2000548320 A JP2000548320 A JP 2000548320A JP 2000548320 A JP2000548320 A JP 2000548320A JP 2002514634 A5 JP2002514634 A5 JP 2002514634A5
Authority
JP
Japan
Prior art keywords
group
substituted
heterocyclic compound
unsubstituted
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000548320A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514634A (ja
Filing date
Publication date
Priority claimed from US09/292,682 external-priority patent/US6184385B1/en
Application filed filed Critical
Publication of JP2002514634A publication Critical patent/JP2002514634A/ja
Publication of JP2002514634A5 publication Critical patent/JP2002514634A5/ja
Pending legal-status Critical Current

Links

JP2000548320A 1998-05-08 1999-05-06 スルフェンイミドの製造方法 Pending JP2002514634A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8482598P 1998-05-08 1998-05-08
US60/084,825 1998-05-08
US09/292,682 1999-04-16
US09/292,682 US6184385B1 (en) 1998-05-08 1999-04-16 Process for the manufacture of a sulfenimide
PCT/US1999/009876 WO1999058516A1 (en) 1998-05-08 1999-05-06 Process for the manufacture of a sulfenimide

Publications (2)

Publication Number Publication Date
JP2002514634A JP2002514634A (ja) 2002-05-21
JP2002514634A5 true JP2002514634A5 (https=) 2006-06-15

Family

ID=26771472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000548320A Pending JP2002514634A (ja) 1998-05-08 1999-05-06 スルフェンイミドの製造方法

Country Status (11)

Country Link
US (1) US6184385B1 (https=)
EP (1) EP1077961B1 (https=)
JP (1) JP2002514634A (https=)
KR (1) KR100582334B1 (https=)
CN (1) CN100339370C (https=)
AU (1) AU3884599A (https=)
BR (1) BR9910304B1 (https=)
CA (1) CA2331969C (https=)
DE (1) DE69911004T2 (https=)
ES (1) ES2207214T3 (https=)
WO (1) WO1999058516A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735170B (zh) * 2008-11-06 2012-10-31 南化集团研究院 N-叔丁基双次磺酰亚胺的制备方法
CN106432000A (zh) * 2016-09-21 2017-02-22 南开大学 由硫醚合成亚磺酰亚胺类化合物的方法
CN106892825A (zh) * 2017-03-09 2017-06-27 河北明翔新材料科技有限公司 一种回收tbsi生产中副产物的方法
WO2024141927A1 (en) * 2022-12-28 2024-07-04 Nitrex Chemicals India Limited A process for the preparation of n, n-disubstituted benzothiazole-2-sulfenamides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3151122A (en) * 1964-09-29 Preparation of n-alkyl- and n-cyclo
NL98032C (https=) * 1957-04-02
DE3137061A1 (de) * 1981-09-17 1983-03-24 Bayer Ag, 5090 Leverkusen N-sulfenylierte benzylsulfonamide, ein verfahren undihre verwendung als mikrobizide
WO1992005218A1 (en) * 1990-09-21 1992-04-02 Uniroyal Chemical Company, Inc. Method of manufacturing a nitrosamine-free rubber article
DE4128682A1 (de) * 1991-08-29 1993-03-04 Bayer Ag Verfahren zur herstellung von bis-benzthiazolyl-alkyl-sulfenimiden
US5204481A (en) * 1992-06-08 1993-04-20 Monsanto Company Process for preparing benzothiazole sulfenimides using an aliphatic hydrocarbon solvent

Similar Documents

Publication Publication Date Title
CO4910135A1 (es) Derivados cetolidos 6-0 sustituidos de la eritromicina que tienen actividad bacteriana
NO20062267L (no) Hepatitt C virus inhibitorer
CA2184919A1 (en) New Piperazine Derivatives and Methods for the Preparation Thereof and Compositions Containing the Same
DK1063228T5 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
WO2004002986A3 (en) Novel benzimidazole derivatives
CA2232728A1 (en) Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
WO2000010965A3 (en) Quaternary ammonium salts and their use as anti-hiv agents
NO20044807L (no) Heratitt C virus inhibitorer
NO20062339L (no) Hepatitt C virus-inhibitoerer
CA2318349A1 (en) Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
RU2219177C2 (ru) Производные бензотиадиазолов, бензоксадиазолов и бензодиазинов, способ их получения и фармацевтическая композиция
ES2124545T3 (es) Azolidindionas como agentes antihiperglucemicos.
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
CA2336412A1 (en) Medicament for treatment of diabetes
ATE13178T1 (de) 2-oxoazetidin-derivate, ihre herstellung und verwendung.
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
CA2241092A1 (en) 1-methylcarbapenem derivatives
CA2369404A1 (en) Method of producing nitroguanidine- and nitroenamine derivatives
JP2002514634A5 (https=)
HUP0100453A1 (hu) Eljárás izokarbamidok előállítására
IE45865L (en) Oxime derivatives of 3-carbamoyloxymethyl-7-¹amino-thiazolylacetamido-ceph-3-em-4-carboxylic acid.
WO2004066725A3 (en) Avermectin- and avermectin monosaccharide derivatives substituted in the 4”- or 4’-position having pesticidal properties
NO20070421L (no) Radiosensitiviserende middel
WO2003014094A3 (de) Heterocyclylarylsulfonamide
HUP9700392A1 (hu) Egy vagy két hatóanyagot tartalmazó kardioprotektív hatású gyógyszerkészítmények